mRNA-LNP vaccination orchestrates systemic immunity to control human papillomavirus-positive head and neck squamous cell carcinoma

Messenger RNA (mRNA) vaccines have demonstrated significant potential in cancer immunotherapy by activating both innate and adaptive immunity. However, the detailed cellular and molecular dynamics underpinning these systemic immune responses remain incompletely understood. In this study, we characte...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ke Qiu, Minzi Mao, Yao Song, Xing Duan, Yufang Rao, Lan Feng, Danni Cheng, Xiuli Shao, Yanling Liang, Chuanhuan Jiang, Hai Huang, Li Li, Yan Wang, Huifang Li, Mengli Zhu, Sisi Wu, Wei Xu, Geoffrey Liu, Jadwiga Jablonska, Stephan Lang, Shuaicheng Li, Fei Chen, Xingchen Peng, Yongbo Zheng, Haiyang Wang, Jun Liu, Yu Zhao, Xiangrong Song, Jianjun Ren
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-12-01
Saila:	Molecular Therapy: Nucleic Acids
Gaiak:	MT: Clinical Applications messenger RNA-lipid nanoparticle vaccination human papillomavirus-positive head and neck squamous cell carcinoma HNSCC systemic immune landscape interferon-stimulated gene
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2162253125003348
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!